Riskpilot← Back to searchSign inGet full accessCB HELSE AS
ASActiveOrg 995694336Hareveien 3, 0491 OsloGeneral medical practice activities · NACE 8621Est. 20101 employees
Revenue 2025
NOK 4,1M
+3% vs 2024
EBITDA margin
51.6%
+4% vs 2024
Equity ratio
96.0%
Financial strength
Net profit 2025
NOK 2M
+69% vs 2024
| Revenue | NOK 4,1M | +3% |
| EBITDA | NOK 2,1M | +4% |
| Net profit | NOK 2M | +69% |
| Total assets | NOK 17,9M | +13% |
| Equity | NOK 17,2M | +13% |
| Employees | 1 | — |
Legal name
CB HELSE AS
Org number
995694336
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
1. juli 2010
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legevirksomhet, kurs-, foredrags- og undervisningsvirksomhet, utarbeidelse av spesialisterklæringer og sakkyndige oppdrag, konsulentvirksomhet foruten finansforvaltning og drift av fast eiendom.
Address
Hareveien 3, 0491 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 202 | 3 281 | 3 648 | 3 985 | 4 115 |
| Staff expenses | −828 | −815 | −1 190 | −815 | −860 |
| EBITDA | 1 359 | 1 434 | 1 507 | 2 044 | 2 122 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 359 | 1 434 | 1 507 | 2 044 | 2 122 |
| Net financials | 782 | −3 262 | 2 091 | −330 | 416 |
| Profit before tax | 2 141 | −1 828 | 3 598 | 1 715 | 2 537 |
| Tax | 310 | 331 | 340 | 535 | 544 |
| Net profit | 1 831 | −2 159 | 3 257 | 1 179 | 1 993 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 13 787 | 11 334 | 14 590 | 15 876 | 17 873 |
| Equity | 13 090 | 10 731 | 13 989 | 15 168 | 17 161 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 697 | 602 | 601 | 709 | 712 |
| Total debt | 697 | 602 | 601 | 709 | 712 |
EBITDA margin
51.6%
This company
15.8%
Market median
+227% vs market
20212025
Equity ratio
96.0%
This company
38.2%
Market median
+151% vs market
20212025
Return on equity
11.6%
This company
18.4%
Market median
+37% vs market
20212025
Net profit margin
48.4%
This company
8.1%
Market median
+498% vs market
20212025
Asset turnover
0.23×
This company
1.12×
Market median
-79% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SH Deputy Member | Deputy Member | 2010 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2010 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CB HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Susanne Haugen Barstad | Deputy Member | 0 companies |
| Christian Barstad | Chairman | 0 companies |